Further characterization of a melanoma-specific protein from human urine. by Bennett, C. & Cooke, K. B.
Br. J. Cancer (1980) 41, 734
FURTHER CHARACTERIZATION OF A MELANOMA-SPECIFIC
PROTEIN FROM HUMAN URINE
C. BENNETT AND K. B. COOKE
From the Physical Biochemistry Lab., Department of Chemical Pathology,
Westminster Medical School, London SW1P 2AR
Received 25 May 1979 Accepted 24 January 1980
Summary.-Isolation of a melanoma-specific protein (MSP) from human urine has
been achieved using antibody affinity chromatography. MSP migrates as a single
homogeneous protein on SDS PAGE and comparison ofthese data and ultracentrifuge
analyses indicates that MSP contains a single polypeptide chain. MSP, however,
shows considerable charge heterogeneity on isoelectric focusing. The desialo form,
a2 MSP, is found predominantly in patients with advanced metastatic disease, whilst
only the sialo form a, MSP, is obtained from the urine of patients with early-stage
disease. MSP does not react with antisera raised to a, foetoprotein (AFP) or carcino-
embryonic antigen (CEA) and hence is immunologically distinct from these other
tumour-associated glycoproteins. Antisera raised to MSP do not react with normal
skin melanocytes nor with any foetal tissue tested, and hence the origin of MSP re-
mains unresolved.
TUMOUR-ASSOCIATED ANTIGENS have
been demonstrated in the nucleolus (Mc-
Bride et al., 1972) in the cytoplasm and
on the surface membrane of malignant
melanoma cells (Lewis, 1967; Morton et al.,
1968; Irie et al., 1975). A number of
laboratories have prepared immunologic-
ally reactive proteins from malignant
melanoma tumour cells (Stuhlmiller et al.,
1978; McCabe et al., 1978; Bystryn &
Smalley, 1977) and joint work by a group
in the U.S.A. and the U.S.S.R. has
identified one such membrane antigen
as a glycolipoprotein (Gorodilova & Hol-
linshead, 1975).
Melanoma-associated antigens in the
uirine ofpatients with malignant melanoma
have been previously described (Jehn etal.,
1970; Carrel & Theilkaes, 1973; Volkers
et al., 1978) and we have found that anti-
serum raised to one such protein, mela-
noma-specific protein (MSP) reacted not
only with the cytoplasm and surface
membrane ofhuman malignant melanoma
cells (Bennett & Cooke, 1978) but also with
the cytoplasm of other aberrant pignment
cells (Bennett & Copeman. 1979). Such
antisera did not react with any other cell
tested (Bennett & Cooke, 1978). We have
described the isolation ofMSP from human
urine (Cooke & Bennett, 1978) and report
here an improved isolation procedure.
Earlier characterization studies indicated
that MSP was a sialo-protein, and in the
present paper results are presented of
further immunological and physico-chemi-
cal characterization.
METHODS AND MATERIALS
Urine samples
Continuous urine collections were obtained
from patients with malignant melanoma and
from laboratory staff. Thymol was used as a
preservative.
Antisera
Heterologous antihuman malignant mela-
noma sera (RAMA) were raised in rabbits
using neuraminidase-treated fresh-frozen cells
according to the method of Ray et al. (1975).
Antisera were raised in rabbits to insolubilized
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on to 200 ,ul Affigel 701 polyacrylamide beads
(BioRad Laboratories) at pH 5-2 for 5 h at
4C, using 2 mg 1-ethyl-3(3-dimethyl amino
propyl) carbodiimide HCl (Sigma Chemical
Co.). The mixture was neutralized with
0-1M NaOH and then used as immunogen.
Two female New Zealand white rabbits were
used for each immunization. On Day 0, 1 ml
of immunogen was mixed with 1 ml of
Freund's Complete Adjuvant (Bacto Adju-
vant Complete-Freunds, Difco Labs.). 0-2 ml
of the suspension was injected s.c. at each of
9 sites, and 041 ml injected i.m. at each of 2
sites. On Day 7, 0 5 ml of immunogen was
mixed with 0 5 ml of Freund's Incomplete
Adjuvant. 0-25 ml of the suspension was
injected i.m. into each hind flank. On Day 14,
0-25 ml of immunogen without adjuvant was
injected i.m. into each hind flank.
On Day 28, rabbits were test-bled. The
serum was tested for antibodies to melanoma-
cell cytoplasm using indirect immune fluores-
cence. Rabbits were bled by cardiac puncture
on Day 29 ifthe antibody result was positive
on Day 28.
Further boosting of rabbits with negative
antisera on Day 28 was not attempted.
Absorption procedures
Pooled human red blood cells (RBC).-
RBC were obtained fresh from heparinized
blood sent forroutine analysis. Care was taken
to select blood from patients with non-
malignant disease. The plasma was removed
from the RBC by centrifugation at 1500 g
for 5 min and the cells were washed x 3 in
PBS. RBC from 10 patients were pooled and
washed once in PBS. RBC from known A and
B donors were always included.
Heterologous antiserum and packed RBC
(1:1 v/v) were mixed on a Matburn mixer for
30 min at ambient temperature, and the cells
removed by centrifugation at 1500 g for 5
min.
Pooled lymphocytes.-Lymphocytes isolated
from peripheral blood using Lymphoprep
(Nyegaard & Co.) were kindly provided by
the staff of the Edmund Fane Laboratory,
Westminster Medical School. In addition,
tonsilectomy specimens removed at operation
werekindly supplied, fresh, by Mr Holborrow,
ENT Surgeon to Westminster Children's
Hospital. These were disaggregated mechan-
ically with scissors and washed x 3 in TC199.
The cells from both sources were pooled and
washed twice in PBS. A pool of 2 x 101(1
cells obtained from 16-20 patients was used
to absorb 10 ml heterologous serum. The cells
were resuspended in the serum, incubated at
37°C for 1 h, and then removed by centrifuga-
tion, as above.
Insolubilized normal human serum proteins
and normal urinary proteins.-51 normal
human urine pool were concentrated on a
DC2 Hollow Fibre system, normal retention
10,000 daltons (Amicon Ltd) to 50 ml, and
to this was added 10 ml normal pooled
human serum. The mixture was dialysed
against 5 1 saline (9 g/l NaCl) at 4°C overnight
with stirring. The immunoabsorbent was pre-
pared according to the method of Avrameas
& Ternynck (1969).
The polymer in PBS was centrifuged at
3000 g for 30 min and the supernatant dis-
carded. About 10 ml of packed polymer was
added to 10 ml antiserum. The mixture was
stirred at room temperature for 1 h on a
Matburn mixer. The suspension was then
centrifuged at 3000 g for 30 min and the
supernatant (absorbedantiserum) retained.
Acetone powders of normal human skin and
normal human organs-.Normal skin and
normal organs (liver, kidney and heart) were
collected at necropsy in sterile containers
containing TC199. The tissues were washed in
PBS to remove any blood, andthenmechanic-
ally disaggregated using scissors. The material
was homogenized for 2 x 5 min at 4°C, using
a Dottingen homogenizer and then centri-
fuged for 20 min at 10,000 g on the HS 65
centrifuge. The supernatant was discarded
and the pellet washed with acetone on a
Buchner funnel and dried overnight at 37°C.
Collection of cultured normal human skin
melanocytes, normal mole and normal skin
fibroblasts
Normal pigmented moles obtainied by
biopsy from patients attending skin clinics
and foreskin from circumcisions were col-
lected in sterile dishes containing TC199.
Preparation oftissues
Normal pigmented moles.-The tissue was
washed thoroughly in PBS (Dulbecco's
Formula Modified without calcium and mag-
nesium-Flow Laboratories) cut into small
pieces using a scalpel and scissors and incuba-
ted at 37°C in a flask containing 5 ml 0-1%
735C. BENNETT AND K. B. COOKE
(v/v) trypsin/EDTA solution (Gibco-Biocult)
in PBS wvith stirring for 1-2 h. Incubation
with trypsin was continued until microscopic
inspection indicated that the cell clusters
were disaggregated. The cells were then
washed x 3 in TC199 and resuspended in
medium to give a solution containing 106
cells/ml. One ml of this suspension was trans-
ferred to a Falcon flask (25 Cm2 surface
growth area) containing 6 ml culture medium.
The cells were grown until confluent. The
culture medium wNas renew ed every 3-4 days.
Normal skin melanocytes and fibroblasts.-
The skin was washe(d thoroughly in PBS
(Dulbecco's Formula Modified with calcium
and magnesium) stretehed out in a Petri dish
containing 20 ml (041% (v/v) trypsin/EDTA
in PBS and incubated at 37°C for 1-2 h. The
dermis was then dissected away froim the
epidermis.
The epideermis was transferred to a Petri
dish containing r5 ml TC199. The tissue w-as
scraped using a scalpel and the resulting cell
suspension washed x 3 in TC199. The cell
deposit w%ras resuspendled to give a solution
containing 104 cells/ml. Oine ml of cell sus-
pension was transferred to a Pulvertaft Ring
Chamber containing 6 ml culture medium and
the cells growin until confluent.
The derinis wsas cut inito smIiall pieces using
scissors, and the tissue was again trypsinized
as described above, washed and resuspended
to give a solution containing 106 cells/ml.
One ml cell suspension was transferred to a
flask (25 cm2 surface growth area) contaiining
6 ml culture mediuml. The cells were grown
until confluenlt.
The culture mediumii for epidermis and der-
mis was renewed every 3-4 days.
Confluent cell growth.-When confluent
cell growth was attained, the culture mediuin
was decanted, and the monolayer washed x 3
in PBS (Dulbeeco's Modified Forimula) to
remove oil antitrypsini (in the bovine foetal
calf serum,) and magnesium and calcium ions
from the medium. 2-5 ml 010/ (w/v) trypsin/
EDTA solution in PBS wNas added to each
flask, wshich was then incubated at 37°C for
5 min or until microscopic inspection of the
flask indicated that the cells were no longer
attached to the glass surface. The cells were
wN-ashed x 3 in TC199. W;here cells wsere not
required for immediate use they were re-
suspended in TC199 conitaining 100' (v/v)
(lilnethyl sulplhoxide at a concentrationi of
3 x 106 cells/ml and stored at - 196TC.
Cultured epidermal cells.-When confluent
cell growth was achieved the culture consisted
of a heterogeneous population of cells. The
major cells present were fibroblasts, Langer-
han's cells, keratinocytes andmelainocytes.
In order to obtain an enrichment ofmelano-
cytic cells in the culture, the "Flip-flop
technique" was carried out. This method
exploits the fact that different cells, become
attached to glass surfaces at different rates.
One ml containing 106/cultured epidermal
cells were seeded in glass Falcon flasks (Corn-
ing surface growth area 25 cm2) containing
6 ml cultured medium. Theflaskwasincubated
at 37°C for 2-4 h. The cells attache(d in this
period were non-melanin-containing cells as
judged by the Fontana stain. 'I'he culture
medium an(d unattached cells were transferred
to a second glass flask. GrowN-th was continued
for 6-16 h, when a substantial number of
keratinocytes will le attached to the glass
surface. and hence cultures prepared represent
a mixed population of melanocytes anid kera-
tinocytes. Th-e attached cells (after 16 hi
incubation) wN-ere removed from the surface by
trypsinizationandsubculturedthroughseveral
passages using the methods described al)ove.
Cell populations prepared by the tissue
culture of epidermiial cells, der-mal cells anid
normal mole were stained for melanin by the
Fontana techlnique (Culling, 1958). 106 cells
were seeded into Pulvertaft culture chambers
and grown for 24 h at 37°C. The coverslips
were reimoved and fixed in formnlaliin for 1 h at
room teimiperature.
EjJicacy of absorption procedutres.-The
methods used to assess the effectiveniess of
the various al)sorptionlprocedures are sumII-
Iiarized1 in Trable I. Hetero-antisera were
tested against fresh cell suspensions of lym-
phocytes froni 10 different noni-melainoma
patients, using the indirect inirnune fluores-
cence teclmique. The procedure wN-as cariied
out in the cold at 4°C according to the method
of Phillips & Roitt (1973). Indirect immune
fluorescenice studies against otlher cells and
tissue sections wNcre performiled accoiding to
the strict criteria of Elliott et al. (1973).
As positive controls for the immune
fluoresceince test anti-f2 microglobulin w%as
tested against lymphocytes, a positive serum
fiom a patient Awith pemiphigus against tissue
sections of niormnal skin and a positive seruii
from a patient with Goodpasture's syndrome
against normal kidney tissue sections. rlhe
efficacy ofabsorption ofheterologous antisera
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against normal humani serumn and urine were
assessed using immnunoelectrophoresis (Schei-
degger & Roulel, 1955).
RAMA and RAMSP were considered to be
fully absorbed when no reaction could be
demonstrated against the various absorbents
by the methods outlined in Table I.
TABLE I.-Procedures for the absorption
and assessmtent ofheterologous antisera
Absorbent Type of
(nlormal tissues) absorbentt
1. Lympliooytes Sinigle cell
(pool)
Mole (pool)
Skin melanoc ytes
Skin fibroblasts
2. Humaii skin Aectoiie
(pool) powders
Kidney
Heart
Lixver
3. Human serrum GCltaralde-
(pool) hyde-iiisoltiblc
Human uirine polymer
AMethlo(I of
assessing
Complete
absorption
Inclirect
immune
fluorescence oII
single cells
Inilirect
immune
fluorescence oni
tissule Sec(tiolls
Immitno-
clcctropliorei.s,;
Isolationb of JISP usingy antib)ody af/inity
chroniatoyraph,y.-RAMA was insolubilized
to AH-Sepharose 4B beads, washed and
packed to form a coluimm-ii of 70 mnl volumiie as
previouisly described (Cooke & Bennett, 1978).
3-9 1 uirine wNNere applied to this column iat
7 lb/in2 and the flow rate regulated to 35 nil/h.
After urine application, the columni wN-as
wiashed with PBS until the eluate absorbance
fell belowN, 0-05 D at 280 nimi. The coluinii was
washed wNith. 0-05mr sodiumn phosphate (pH
5 0) containinig 0d1Mr NaCl, to remove Inoni-
specifically adsorbed proteins (Bennett. 1978)
and finally eluted with Oi%r propionic acid
(pH 2.5).
After acid elution. fractioins conitaininig
protein wrere pooled, neutralized, dlialysed
and finally concentrated by ultrafiltration
using a UMlO mueImbranie (AI11icoIn Ltd). The
protein concentration of the solution was
determined 1sinIog the modified Folin and
Lowry procedure (Hartree, 1972) and bovine
serum albumin (Armour Pharmaceuticals
Ltd) as a standard.
specificity of thie a4finity chrom?iatoyraphy
pr-ocedurn-e. The specificity of the rlabbit
anti-humlnan melanoma serum immunoabsor-
bent w-as assessed by applying 8-16 1 normal
urine to the immune coluinn. In addition an
equivalent norinal rabbit serumi column was
prepared. The insolubilization and washing
procedures were idcentical to those described
for the preparation of the immune column.
Seven litres of pooled melanotic urinie were
applied to this column and eluted using the
conditions described above.
Finial purification of JISP pr-eparation.
MSP prepared by a'ntibody affinity chromato-
graphy was rechromatographed on a 3g
AH Sepharose 4B column (4 cm x 7 mm) to
which 1-2 ml anti-pathological human urine
protein antiserum (Dakopatts A.S., Copen-
hagen) was covalently attached.
Treatment of MISP with neuramninidase.
Native MSP wNas treated with neuraminidase
(lVibrio cholerae neuraminidase 500 u/ml-
Hoechst Pharinaceuticals AG) as previously
(lescribed (Bennett & Cooke, 1978).
Lnn1mItnloloyical specificity of MSP.-MSP
)reparations -were tested against antisera
raised to AFP, CEA and lactoferrin (Dako-
patts A.S., Copenlhagen) using micro-immuno-
electrophoresis (Scheidegger & Roulel, 1955)
and double-diffusion in agarose gels (Ouch-
terlony, 1949).
Further specificity of RAMA and RAMSP.
-Using indirect immune fluorescence tech-
niques, RAMA. and RAMSP w-ere tested
against longitudinal tissue sections through a
33-day-old foctus, ancd on tissue sections
through numerous tissues (cerebellus, kidney,
thymus, liver, spleen, thyroid, heart, intes-
tine, skin, eye) from a foetus of 18-22 weeks'
gestation. iPreparation of tissue sections as
well as the immnunological technique wAere
performed as described by Bennett & Cope-
nan (1979).
Conwcentration 1radieWmt polyacrylainide elec-
trophoresis. Polyacrylaiimide gel slabs (75x
75 x 2 5 mm) with a concave gradient of 2-5-
280% (w/v) polyacrylaiinide (Universal Scieni-
tific Ltd) were used. Electrophoresis was
carried out according to the procedure of
Leaback (1976) with tris/EDTA/borate l)uffer
(pH 8 9). Gels were run for 3 h at 250 V at
40C, and then stained with Naphthalene
Black 12B (Kohn, 1976).
Isoelectric focusiiq (IEF).-IEF was per-
formed in polyacrylainide gels as described
by Righetti & Drysdale (1971) -with the
following modifications: the gels, cast in glass
tubes (5 mm bore x 105 mm length) contained
7-5% (w/v) aciylamide, 0 250o (wN/v) bis-
acrylamide, 500 (w/v) glycerol atnd 500 (w/v)
ampholytes (LKB productor 400o w/v). The
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gels were run for 18 h at constant voltage
(200 V). The pH gradient wvas determined by
slicing a control gel into sections 0 5 cm in
length. Each section was eluted with
2 ml distilled water and the pH measured
using a pH meter with an expansion scale
(Radiometer TTT1 with PHA 630 Ta). The
gels were stained with "Stains All" (Green
et at., 1973).
Molecular-weight determinations.-Molecu-
lar-weight determinations in polyacrylamide
gels were performed according to the pro-
cedure of Weber & Osbourne (1975). Samples
were treated with sodium dodecyl sulphate
(SDS-lg/100 ml) and with 1 g/100 ml mer-
captoethanol in 0dIM phosphate buffer (pH
7-2) followed by electrophoresis in 7-50o (w/v)
polyacrylamide gels containing 0-2 g/100 ml
SDS in 0-2M phosphate buffer (pH 7.2).
Estimation of dry weight.-The dry weight
of the protein was determined using alu-
minium micropans in a muffle furnace at
1000C and 500°C. The pans were weighed on a
Cahn Electrobalance. Control blank pans did
not change weight during this procedure.
Specific extinction in the near and far
ultraviolet.-The specific extinction (E'l%)
for MSP in 0 05m NaCl at 280 nm and
210 nm was determined on aliquots and dilu-
tions of the solution used for the dry weight
determination, according to the procedure of
Tombs et al. (1959) using an Optica CF4N1
recording spectrophotometer.
Partial specific volume.-was determined
using a digital density meter DMA 02C
(Anton Parr K.G.), (Kratby et al., 1969).
Ultracentrifuge analyses. were performed
in an MSE ultracentrifuge using 10mm
double-sector cells. Samples were dialysed
against the reference buffer overnight (0-05M
Na phosphate, 0-15M NaCl (pH 7.4)).
For sedimentation velocity runs at 60,
670 rev/min a protein concentration of250 ,tg/
ml was used in conjunction with an MSE
scanner system using locally modified pseudo-
Schlieren optics and a solid knife edge at bar
angle 50°. Data were directly digitized and
sedimentation coefficients calculated from
log sq. root ofthe second moment (Armstrong,
1966) using an IBM 1800 computer.
For sedimentation equilibrium runs a 3mm
column and a protein concentration of2-0 mg/
ml was used with interference optics, a mono-
chromatic sodium light source and sapphire
windows. Fringedisplacements were measured
on a Projectorscope III measuring micro-
scope (Precision Grinding Ltd). Experiments
were run for 30 h at 30,340 rev/min using a
high speed equilibrium technique (Yphantis,
1964).
Chromatography on selected lectins.-Con-
canavalin A-Sepharose 4B (Con A) and
wheat-germ-Sepharose 4B were obtained
from Pharmacia. Crotalariajuncae-Sepharose
4B was the kind gift of Dr Vretblad (Phar-
macia A.B.). MSP (1 mg/ml) was chromato-
graphed on the lectin columns (5 x 50 mm)
using the following elution conditions: Con.
A columns were eluted sequentially with
10% (w/v) oa-D-methyl glucoside, 10% (w/v)
a-D-methyl mannoside and 01M sodium
borate buffer pH 6-0 (SB buffer). Wheat-
germ columns were eluted sequentially with
100 g/l N-acetyl glucosamine in 0-5M sodium
phosphate (pH 7 0) containing 0(2M NaCl
and with SB buffer (pH 6). Crotalaria
juncae columns were eluted sequentially with
0-2M galactose in 0dIm PBS (pH 7.4) followed
bv SB buffer (pH 6 0).
Absorption ofantisera with purified MSP
The procedure we have previously de-
scribed for the detection of MSP in urine
(Bennett & Cooke, 1978) was used to test the
effect of purified MSP on RAMA. A mixture
of 50 ,ug MSP and 20 mg human serum albu-
min (HSA) was insolubilized on to 500 mg
AH Sepharose 4B beads at pH 5-2-5-5 over-
night at 4°C using 20 mg 1-ethyl-3(3 dimethyl
amino propyl)-carbodiimide HCI. The beads
were washed to remove unreacted protein and
reagents, resuspended in 0 5 ml diluteRAMA
(1 ml RAMA+7 ml PBS) and reacted at room
temperature for 60 min at neutral pH on a
Matburn mixer. After filtration on a sinter
funnel, the filtrate (absorbed antiserum) was
used to stain snap-frozen human melanoma
cells by the indirect fluorescence technique.
A similar experiment was performed with
RAMSP. It was necessary to use a carrier
protein (HSA) to minimize carbodiimide
cross-linked aggregation of MSP during
insolubilization. As a control, 20 mg HSA
without MSP was insolubilized and tested
using the same procedure.
RESULTS
Heterologous antihuman malignant
melanoma antisera (RAMA) and hetero-
logous anti-MSP (RAMSP) reacted with
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TABLE II. Specificity of
human malignant mela
Tissue
Ofneural crest origin
Malignant
Malignant melanoma*
Neuroblastoma*
N
spel
Non-malignant
Active halo naevust
Vitiligot
Melanocytes*
Naevus cells*
Adrenal medulla
Foetal tissuet
Foetal skin
(melanocytes, 22-wk
gestation)
Eye (choroid):
Section through
33-day-old foetust
Other
Malignant
Hypernephroma*
Ca Breast*
Ca Colon*
Osteosarcoma*
Foetal (22-wk gestation)
Cerebellum, kidney,
Thymus, liver, spleen,
Thyroid, heart, intestine
* Single-cell suspensions.
t Tissue sections.
t Longitudinal section.
heterologous anti- the surface membrane and cytoplasm of
inoma antisera all malignant melanoma cells tested by the
Indirect indirect immune fluorescence test. The
immune immune antisera (Table II) did not cross-
fluorescence react with foetal tissue (from a foetus of
cto lasm 18-22 weeks' gestation) normal adult skin
oftissue melanocytes or with the embryonically
using related tumour, neuroblastoma. Similarly
ro. of heterologous . '.
cimens antisera no cross-reactivity could be demonstrated
against longitudinal sections through a
33-day-old foetus by immune fluorescence
70 70 techniques. 5 0
1
1
3
3
1
1
1
14
3
2
1
From
one
foetus
I
0
0
Studies on the chromatographic procedure
(Table III)
0 Attempts were made to reduce the urine
volume by concentrating it by ultra-
filtration through UMIO membranes (5 1
urine to 100 ml) or by desalting and
0 lyophilizing the urine before chromato- 0 graphy.
0 No protein was desorbed on acid elution
with propionic acid, and it was concluded
that MSP was not stable to these proce-
°0 dures.
O In the absence of the pH 5*0 buffer,
0 1*6 mg (<<0.01%) total urine protein was
elutedbypropionic acidwhen 7 1 melanotic
0 urine was chromatographed on the non-
immune column, whereas 1 0 mg (e< 0 I%)
total urine protein was obtained by acid
elution when 8 1 normal urine was applied
to the immunoabsorbent. Since each
TABLE III.-Acid desorption of urine proteins from immune and non-immune columns
% total
protein
Total Amount of protein desorbed desorbed
protein (mg)* by acid elution on elution
Urine applied to at with 1-OM
volume column I propionic
Absorbent Urine (1) (mg)* pH 5Ot pH 2-5T acid
Immune Pooled
melanotic
urine
Immune Pooled
normal
urine
Non-immune Pooled
melanotic
urine
9 3600
9 4140
8 1200
16 3000
1-0
1-4
3200
21-0
400
1-0
1-6
* Measured by modified Folin and Lowry method (Hartree, 1972).
t 0-05M Na2HPO4/NaH2PO4, containing 0-1M NaCl.
t 1I01 propionic acid.
0-6
1-0
<0-1
<0-1
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column contained 25 g AR1 Sepharose 4B,
the nonspecific absorptive capacity of the
column material was 50 jg protein/g
AH Sepharose 4B.
Elution of the immune column with the
pH 5 buffer before desorption with pro-
pionic acid removed these nonspecifically
absorbed proteins (Table III).
SDS-PAGE analysis of the protein
fraction eluted from.the immune column
by the pH5 buffer showed that 2 proteins
were present in this fraction, with mol. wts
of 68,000 and 32,000 respectively. The
protein of mol. wt 68,000 was identified
as albumin by double diffusion in agar,
whilstthe protein ofmol. wt 32,000 daltons
could not be identified immunologically
using antisera raised in rabbits to human
serum proteins and pathological urine
proteins. No bands corresponding to MSP
were visible on the SDS gel.
MSP was specifically desorbed as a
single peak from the inmmlune column by
1-OM propionic acid (pH: 2.5) when melan-
otic urine was clhromatographed on the
absorbent. Although no detectable pro-
tein was eluted from the immune absor-
bent whben normal urine was applied to the
column, transferrin, albtumin and oroso-
mucoid were identified as contaminants in
MSP preparations using Ouchterlony im-
munodiffusion analysis. Attempts to quan-
titate these contaminants by Laurell
rocket immunoelectrophoresis showed
them to be mntuch lower than the lowest
standard concentrationi used. On this basis
impurities present in MSP preparations,
determined by summing the concentration
ofthe lowest protein standards used, were
< 6 5% of the total protein in the MSP
preparation.
These remaining contaminants were
subsequently removed by rechromato-
graphing MSP on an immunoabsorbent
to which specific antibodies to patho-
logical urine proteins were inisolubilized.
Physiochentical characterization of MSP
The partial specific volume of MSP was
calculated to be 0-726 ml/g and the specific
FIa. 1. MAolecular-weight determination of
AISP using SDS polyacrylamide electro-
plioresis
Channel: 1. Native (cyl) MSP (25 ,ug).
2. Protein standards (Sigma Clhemical Co.
Ltd.)
a. Bovine serum albumin
b. Ovalbumin (egg)
c. Pepsin (porcine stomaclh)
d. PAISF trypsinogen (bovine
pancreas)
e. Lactoglobulin (bovine milk)
f. Lysozyme (eggwhite)
3. Desialo (a2)MSP (75 ,ug).
AMol. vt
66,000
45,000
34,700
24,000
18,400
14,300
extinctions at 280 nm and 210 nm to be
11.0 and 179-0 respectively.
Both native and desialo MSP migrated
as a single homogeneous band on SDS
polyacrylamide electrophoresis (Fig. 1).
The sialo protein had a mol. wt of 76,000
which fell to 62,000 after neuraminidase
treatment. Ultracentrifuge analysis indi-
cated that MSP sedimented as a 4 8S
protein at high dilution and had a mol. wt
of 72,000. The close agreement between
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Fia. 2. Isoelectric focusinig of MISP in
polyacrylamide gels.
Clhannel: 1. Sialo AISP (200 ag).
2. Neuraminidase-treatel AIISP
(200 ag).
the mol. wts determined in the ultra-
centrifuge and on SDS-PAGE after treat-
ment with mercaptoethanol indicate that
MSP consists of a single polypeptide chain.
The native protein was isoelectric at
pH 3.8 and gave a major component at
pH 4-1 with minor components isoelectric
at pH 4.4 and pH 4-6 after treatment with
neuraminidase (Fig. 2).
Storage of native MSP at -20°C (1
week) produced 2 components on gradient
gels, with the mobility of the sialo and
desialo forms of MSP. This pattern of a
mixture of sialo and desialo MSP was also
a particular feature of MSP preparations
obtained from urine of patients with
advanced disease. Only the sialylated form
was obtained when MSP was prepared
from the urinie ofpatients with early stage
disease.
Gradient polyacrylamide electrophoresis
offractions eluted from the lectin columns
indicated that a2 MSP was'eluted from
Con A by Io0o w/va-D-methyl mannoside,
whilst it was desorbed fronm the wheat-
germ lectin by 10% xw/v N-acetyl gluco-
samine. No bands corresponding to 0X2
MSP were seen in any of the fractions
eluted fromn t,he Crotalaria juncae lectin
column. al MSP was not recovered from
any lectin tested. The protein concentra-
tions of various fractions eluted from each
column were summed and expressed as a
percentage of the total protein initially
added to the column. Only 10% and 500
of the protein originally added to Con A
and wheat-germ lectin columns was eltuted
by the respective specific sugars. Addi-
tional protein was not desorbed by further
eluting the lectin columns with sodium.
borate buffer (pH 6.0).
Iimmtnological ch.aracter,ization of ]ISP
MSP did not react with anti-CEA, anti-
lactoferrin or anti-AFP sera using douible
(lifftsion in agarose and micro-immuno-
electrophoresis.
Insolubilized MSP completely absorbed
the antibody activity of both RAAMA and
RAMSP in the indirect fluorescence test.
No similar suppression ofantibody activity
was seen using a control of 20 mg HSA
similarly treated. Under the conditions
used, 50 4g MSP completely inhibited
9*5 ml dilute antiserum (i.e. 60 yu neat
antiserum) in each case. Since the in-
solubilization technique is only 80% effi-
cient, no precise titre of MSP against
antiserum was attempted.
DISCUSSION
Immunoadsorption has been widely
used for the isolation of antigens, and
allows efficient purification of proteins in
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low concentration from complex solutions
in a single-step procedure (Zoller&Matzku,
1976). Various pre-elution schedules (Yon,
1972; Inman and Dintzis, 1969) have been
used to overcome nonspecific adsorption
effects before desorption of specifically
bound protein. We have found that pre-
elution of the immune column with 0-05M
phosphate (pH 5.0) containing 01M NaCl
was effective in removing nonspecifically
bound material, whilst specifically bound
antigen (MSP) was eluted by I-OM pro-
pionic acid (pH 2.5). MSP isolated from
patients with early-stage disease (Stage I)
was stable at 40C but storage at - 200C
produced 2 electrophoretic components on
concentration-gradient polyacrylamide
gels with the mobility of the sialo and
desialo forms of the glycoprotein (ac, and
0x2 MSP). Whilst this may indicate that
sialic acid residues are particularly labile,
the desialo form could arise from concen-
tration, during freezing, of traces of pro-
pionic acid (freezing point - 20 8°C) with
consequent acid hydrolysis of the sialo
protein. However, MSP prepared from the
urine ofpatients with advanced metastatic
disease consistently contained both a,
and La2 MSP before freezing. The urine
collection and manipulation procedures
before storage were identical for all urine
collections, and hence it seems unlikely
that different handling procedures were
responsible fortheseobservations. Whether
the appearance of a,x and a2 MSP in
advanced-stage urine represents 2 genetic-
ally different proteins, post-synthetic
modification (e.g. by release of lysosomal
enzymes by necrotic tumours) or allo-
morphic variation has yet to be ascer-
tained. Sharif et al. (1978) have reported
that there is enhanced lectin binding by
neuraminidase-treated glycoprotein, but
Stage III cZ2 MSP is retained less strongly
than sialo (oxi) MSP bv Con A and wheat-
germ lectins, and this could indicate
that this form has suffered loss of those
sugars which interact with the lectins,
possibly due to an oligosaccharide deletion
by the mechanism proposed by Hill et al.
(1979).
A possible explanation for the low
recovery ofMSP from lectin columns may
be that the binding constant of the glyco-
protein to the lectin may be several orders
of magnitude greater than that of the
corresponding specific free sugar contained
within that glycoprotein. Thus the specific
sugar would be unable to compete effec-
tively with the glycoprotein conjugate for
specific sites on lectin columns.
In an attempt to establish whether
MSP represents a new tumour protein or
just a re-expression of a previously des-
cribed protein, its properties have been
compared to those of other established
tumour markers and to previously de-
scribed human melanoma proteins. Whilst
the mol. wt is ofthe same order as that for
lactoferrin (90,000) and for AFP (69,000)
(Ruoslahti & Sappala, 1971) MSP did not
form precipitin lines with specific antisera
to either of these proteins, or with mono-
specific anti-CEA antiserum, and must be
considered immunologically distinct. Fur-
thermore both CEA andlactoferrinmigrate
as :3 globulins in electrophoresis and,
whilst AFP does behave as an a, globulin,
its pl at 4-8 (Ruoslahti & Sappala, 1971)
is significantly different from that of
either oil MSP (3.8) or 012 MSP (4.1).
Comparison with other human melan-
oma proteins is more difficult, because of
the lack of detailed physicochemical
studies. Gorodilova & Hollinshead (1975)
describe theirprotein asalipo-glycoprotein
and Hollinshead has quoted a mol. wt
of 100,000 for this protein (Hollinshead,
personal communication, 1979) but we
have no evidence for a ganglioside struc-
ture in MSP. The proteins described by
Jehn etal. (1970) andby Carrel & Theilkaes
(1973) both have /-globulin mobilities
and lower mol. wt ( < 40,000 and 40-60,000
respectively) differences which would in-
dicate that MSP is distinct from the
proteins described by the other groups.
It seems unlikely that 3 groups would
each detect separate distinct, unique pro-
teins in urine from patients with mela-
noma, but no relationship between them
has yet been demonstrated.
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Antisera raised either to MSP or to
malignant melanoma cells reacted with
the cytoplasm and surface membrane of
malignant melanoma cells, but did not
react with normal skin melanocytes or
neuroblastoma cells (Bennett & Cooke,
1978) nor did they react with any foetal
tissue tested and hence the origin of MSP
remains unresolved.
The immunological andphysicochemical
data presented here show that MSP is
distinct from AFP and CEA, the 2 most
similar ofthe previously described tumour
markers, and must be considered as a new
tumour-associated protein. In its apparent
absence from both foetal and normal adult
tissues it resembles the human nephro-
blastoma antigen described by Burtin &
Gendron (1973).
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